Information Provided By:
Fly News Breaks for September 14, 2015
AZN
Sep 14, 2015 | 06:12 EDT
Deutsche Bank upgraded AstraZeneca to Buy citing a positive risk/reward following the recent underperformance of shares. Shares are attractive as the company nears a return to growth in 2017, Deutsche believes. It has a price target of 5,700p for the stock.